436 related articles for article (PubMed ID: 17573534)
1. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.
Parkin ET; Watt NT; Hussain I; Eckman EA; Eckman CB; Manson JC; Baybutt HN; Turner AJ; Hooper NM
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11062-7. PubMed ID: 17573534
[TBL] [Abstract][Full Text] [Related]
2. Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein.
Griffiths HH; Whitehouse IJ; Baybutt H; Brown D; Kellett KA; Jackson CD; Turner AJ; Piccardo P; Manson JC; Hooper NM
J Biol Chem; 2011 Sep; 286(38):33489-500. PubMed ID: 21795680
[TBL] [Abstract][Full Text] [Related]
3. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
5. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein.
Hooper NM
Biochem Soc Trans; 2005 Apr; 33(Pt 2):335-8. PubMed ID: 15787600
[TBL] [Abstract][Full Text] [Related]
6. Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.
Lewis V; Whitehouse IJ; Baybutt H; Manson JC; Collins SJ; Hooper NM
PLoS One; 2012; 7(2):e31754. PubMed ID: 22363722
[TBL] [Abstract][Full Text] [Related]
7. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
8. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A; Hata S; Suzuki T
J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
10. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
[TBL] [Abstract][Full Text] [Related]
11. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
[TBL] [Abstract][Full Text] [Related]
12. Impact of the cellular prion protein on amyloid-β and 3PO-tau processing.
Schmitz M; Wulf K; Signore SC; Schulz-Schaeffer WJ; Kermer P; Bähr M; Wouters FS; Zafar S; Zerr I
J Alzheimers Dis; 2014; 38(3):551-65. PubMed ID: 24028865
[TBL] [Abstract][Full Text] [Related]
13. Loss of cleavage at β'-site contributes to apparent increase in β-amyloid peptide (Aβ) secretion by β-secretase (BACE1)-glycosylphosphatidylinositol (GPI) processing of amyloid precursor protein.
Vetrivel KS; Barman A; Chen Y; Nguyen PD; Wagner SL; Prabhakar R; Thinakaran G
J Biol Chem; 2011 Jul; 286(29):26166-77. PubMed ID: 21642424
[TBL] [Abstract][Full Text] [Related]
14. A new take on prions: preventing Alzheimer's disease.
Hooper NM; Turner AJ
Trends Biochem Sci; 2008 Apr; 33(4):151-5. PubMed ID: 18343669
[TBL] [Abstract][Full Text] [Related]
15. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
[TBL] [Abstract][Full Text] [Related]
16. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
17. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
[TBL] [Abstract][Full Text] [Related]
18. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
19. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.
Taylor DR; Hooper NM
Semin Cell Dev Biol; 2007 Oct; 18(5):638-48. PubMed ID: 17822928
[TBL] [Abstract][Full Text] [Related]
20. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
